Retatrutide targets three receptors (GLP-1, GIP, glucagon) and produced 28.7% weight loss
Professor Chen Wei, Department ofClinical Nutrition, Chinese Academy of Medical Sciences & PekingUnion Medical College, said: "In view of the limited clinical status ofdrugs approved for obesity treatment in China over the past 20 years, newmedical weight loss drugs can provide patients with safe, effective andconvenient treatment options, and can help Chinese obese patientsscientifically manage their weight and related disease risks and improve theirquality of life, which has a profound impact on the clinical practice ofobesity and related diseases." Reference: 1
Studies investigating the relative selectivity of PT-141 vs MT-II across the melanocortin receptor family contribute to understanding which receptor subtype drives which observed effect
Technical issues : If you struggle with using the injection pen or feel uncertain about any step, ask for a demonstration or further instructions
Last month, FDA approved the 3rd generic liraglutide injection, following up from it's 1st generic approval for this GLP-1 receptor agonist drug just 9 months earlier
95% CI 0.500.71
